Category: Business

Aerie Pharmaceuticals Announces Novel Dry Eye Product Candidate AR-15512 (TRPM8 Agonist) Ophthalmic Solution Achieved Statistical Significance Over Multiple Symptoms and Signs in Successful Phase 2b Clinical Study for the Treatment of Dry Eye Disease

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…

Warby Parker Announces Investor Day

NEW YORK–(BUSINESS WIRE)–Warby Parker Inc., a founder-led direct-to-consumer lifestyle brand, today announced that it will hold an Investor Day Monday, September 13th. The pre-recorded event will be available beginning at 11 a.m. ET/8:00 a.m. PT. Reg…